Related Experiment Video
Updated: May 18, 2026
08:30
Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots
Published on: June 2, 2015
Lifestyle factors increasing adiponectin synthesis and secretion
Justine M Tishinsky1, David J Dyck, Lindsay E Robinson
1Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada.
Vitamins and Hormones
|September 29, 2012
Summary
Strategies to boost adiponectin, an anti-inflammatory hormone, are crucial for improving insulin sensitivity. Lifestyle factors like diet and weight loss show promise in enhancing adiponectin levels.
Area of Science:
- Endocrinology
- Metabolic Research
Background:
- Adiponectin, an anti-inflammatory adipokine, improves insulin sensitivity in muscle and liver.
- Obesity impairs adiponectin secretion, necessitating strategies to enhance its levels.
Purpose of the Study:
- To explore lifestyle factors that influence adiponectin synthesis and secretion.
- To understand the mechanisms underlying adiponectin regulation.
Main Methods:
- Review of evidence on lifestyle interventions affecting adiponectin.
- Analysis of molecular pathways involved in adiponectin regulation.
Main Results:
- Dietary long-chain n-3 polyunsaturated fatty acids (PUFA), thiazolidinedione (TZD) administration, and weight loss increase adiponectin.
- Chronic exercise shows variable effects on adiponectin, independent of weight loss.
Conclusions:
- Lifestyle modifications can enhance adiponectin, benefiting lipid metabolism and insulin sensitivity.
- Further research is warranted to identify optimal strategies for increasing adiponectin.
More Related Videos
Related Concept Videos
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:30Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...